Efficacy and safety of cap-assisted endoscopic mucosal resection for treatment of nonlifting colorectal polyps

V. R. H. Van Der Voort; L. M. G. Moons; W. De Graaf; R. W. M. Schrauwen; W. L. Hazen; T. C. J. Seerden; F. P. Vleggaar; P. Didden

doi:10.1055/a-1559-2391

Efficacy and safety of cap-assisted endoscopic mucosal resection for treatment of nonlifting colorectal polyps

V. R. H. Van Der Voort, L. M. G. Moons, W. De Graaf, R. W. M. Schrauwen, W. L. Hazen, T. C. J. Seerden, F. P. Vleggaar, P. Didden^*

^*Corresponding author for this work

Gastroenterology & Hepatology

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Abstract

Background Suboptimal lifting increases complexity of endoscopic mucosal resection (EMR) for benign colorectal polyps. Cap-assisted EMR (EMR-C) may allow fibrotic polyp tissue to be captured in the snare. This study evaluated the efficacy and safety of EMR-C for benign nonlifting colorectal polyps. Methods This was a multicenter study, which prospectively registered all EMR-C procedures (2016 2018) for presumed benign nonlifting colorectal polyps. Results 70 nonlifting polyps with a median size of 25mm (interquartile range [IQR] 15 40) were treated with EMRC. Complete polyp removal was achieved in 68 (97.1%), including 47 (67.1 %) with EMR-C alone. Overall, 66 polyps showed benign histology, and endoscopic follow-up after a median of 6 months (IQR 6 10) showed recurrence in 19.7%. First (n = 10) and second (n = 2) benign recurrences were all treated endoscopically. Deep mural injury type III V occurred in 7.4% and was treated successfully with clips. Conclusion EMR-C may be an alternative therapeutic option for removal of benign nonlifting polyp tissue. Although recurrence still occurs, repeat endoscopic therapy usually leads to complete polyp clearance.

Original language	English
Pages (from-to)	509-514
Number of pages	6
Journal	Endoscopy
Volume	54
Issue number	5
DOIs	https://doi.org/10.1055/a-1559-2391
Publication status	Published - 1 May 2022

Bibliographical note

Access to Document

10.1055/a-1559-2391

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115200157&doi=10.1055%2fa-1559-2391&partnerID=40&md5=8ec86b199cda5e1e2e7065494fbc924b

Cite this

@article{6d741275fab64d0e826c00428b8d7821,

title = "Efficacy and safety of cap-assisted endoscopic mucosal resection for treatment of nonlifting colorectal polyps",

abstract = "Background Suboptimal lifting increases complexity of endoscopic mucosal resection (EMR) for benign colorectal polyps. Cap-assisted EMR (EMR-C) may allow fibrotic polyp tissue to be captured in the snare. This study evaluated the efficacy and safety of EMR-C for benign nonlifting colorectal polyps. Methods This was a multicenter study, which prospectively registered all EMR-C procedures (2016 2018) for presumed benign nonlifting colorectal polyps. Results 70 nonlifting polyps with a median size of 25mm (interquartile range [IQR] 15 40) were treated with EMRC. Complete polyp removal was achieved in 68 (97.1%), including 47 (67.1 %) with EMR-C alone. Overall, 66 polyps showed benign histology, and endoscopic follow-up after a median of 6 months (IQR 6 10) showed recurrence in 19.7%. First (n = 10) and second (n = 2) benign recurrences were all treated endoscopically. Deep mural injury type III V occurred in 7.4% and was treated successfully with clips. Conclusion EMR-C may be an alternative therapeutic option for removal of benign nonlifting polyp tissue. Although recurrence still occurs, repeat endoscopic therapy usually leads to complete polyp clearance.",

author = "{Van Der Voort}, {V. R. H.} and Moons, {L. M. G.} and {De Graaf}, W. and Schrauwen, {R. W. M.} and Hazen, {W. L.} and Seerden, {T. C. J.} and Vleggaar, {F. P.} and P. Didden",

note = "Copyright {\textcopyright} 2022, Rights Managed by Georg Thieme Verlag KG Stuttgart • New York",

year = "2022",

month = may,

day = "1",

doi = "10.1055/a-1559-2391",

language = "English",

volume = "54",

pages = "509--514",

number = "5",

}

TY - JOUR

T1 - Efficacy and safety of cap-assisted endoscopic mucosal resection for treatment of nonlifting colorectal polyps

AU - Van Der Voort, V. R. H.

AU - Moons, L. M. G.

AU - De Graaf, W.

AU - Schrauwen, R. W. M.

AU - Hazen, W. L.

AU - Seerden, T. C. J.

AU - Vleggaar, F. P.

AU - Didden, P.

PY - 2022/5/1

Y1 - 2022/5/1

N2 - Background Suboptimal lifting increases complexity of endoscopic mucosal resection (EMR) for benign colorectal polyps. Cap-assisted EMR (EMR-C) may allow fibrotic polyp tissue to be captured in the snare. This study evaluated the efficacy and safety of EMR-C for benign nonlifting colorectal polyps. Methods This was a multicenter study, which prospectively registered all EMR-C procedures (2016 2018) for presumed benign nonlifting colorectal polyps. Results 70 nonlifting polyps with a median size of 25mm (interquartile range [IQR] 15 40) were treated with EMRC. Complete polyp removal was achieved in 68 (97.1%), including 47 (67.1 %) with EMR-C alone. Overall, 66 polyps showed benign histology, and endoscopic follow-up after a median of 6 months (IQR 6 10) showed recurrence in 19.7%. First (n = 10) and second (n = 2) benign recurrences were all treated endoscopically. Deep mural injury type III V occurred in 7.4% and was treated successfully with clips. Conclusion EMR-C may be an alternative therapeutic option for removal of benign nonlifting polyp tissue. Although recurrence still occurs, repeat endoscopic therapy usually leads to complete polyp clearance.

AB - Background Suboptimal lifting increases complexity of endoscopic mucosal resection (EMR) for benign colorectal polyps. Cap-assisted EMR (EMR-C) may allow fibrotic polyp tissue to be captured in the snare. This study evaluated the efficacy and safety of EMR-C for benign nonlifting colorectal polyps. Methods This was a multicenter study, which prospectively registered all EMR-C procedures (2016 2018) for presumed benign nonlifting colorectal polyps. Results 70 nonlifting polyps with a median size of 25mm (interquartile range [IQR] 15 40) were treated with EMRC. Complete polyp removal was achieved in 68 (97.1%), including 47 (67.1 %) with EMR-C alone. Overall, 66 polyps showed benign histology, and endoscopic follow-up after a median of 6 months (IQR 6 10) showed recurrence in 19.7%. First (n = 10) and second (n = 2) benign recurrences were all treated endoscopically. Deep mural injury type III V occurred in 7.4% and was treated successfully with clips. Conclusion EMR-C may be an alternative therapeutic option for removal of benign nonlifting polyp tissue. Although recurrence still occurs, repeat endoscopic therapy usually leads to complete polyp clearance.

UR - http://www.scopus.com/inward/record.url?scp=85115200157&partnerID=8YFLogxK

U2 - 10.1055/a-1559-2391

DO - 10.1055/a-1559-2391

M3 - Article

VL - 54

SP - 509

EP - 514

IS - 5

ER -

Efficacy and safety of cap-assisted endoscopic mucosal resection for treatment of nonlifting colorectal polyps

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this